Metformin Sr Crescent Pharma

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Sr Crescent Pharma (Metformin Hydrochloride)

Q: What is Metformin Sr Crescent Pharma used for?

Metformin Sr Crescent Pharma contains metformin hydrochloride, a Biguanide indicated for the management of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving the body’s response to insulin and reducing hepatic glucose output.

Q: How does metformin work in the body?

Metformin acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis. It also activates AMP‑activated protein kinase (AMPK), enhancing peripheral insulin sensitivity and decreasing intestinal glucose absorption, thereby lowering overall blood glucose.

Q: What is the usual dose of Metformin Sr Crescent Pharma?

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Q: Is Metformin safe to use during pregnancy or breastfeeding?

Metformin may be prescribed during pregnancy for certain indications such as gestational diabetes, but the decision rests with the obstetrician. Limited data are available for breastfeeding; the prescriber should weigh potential benefits against any possible risks to the infant.

Q: How do I order Metformin Sr Crescent Pharma from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Q: How does Metformin compare with other antidiabetic drugs?

Metformin is often preferred as first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycemia when used alone. Compared with sulfonylureas or insulin, it has a different mechanism—targeting hepatic glucose production rather than stimulating insulin secretion.

Q: What are the recommended storage conditions for Metformin Sr Crescent Pharma?

Store the product at ambient temperature, below 25 °C, in the original packaging. Keep it away from moisture, direct sunlight, and heat sources to maintain stability and potency throughout its shelf life.

Q: How is Metformin Sr Crescent Pharma administered?

Metformin Sr Crescent Pharma is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water; they should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

Q: What are the most serious risks associated with Metformin?

The most serious risk is lactic acidosis, a rare but life‑threatening condition that can occur in patients with severe renal or hepatic impairment, or after exposure to iodinated contrast. Prompt medical attention is required if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Q: Who should not use Metformin Sr Crescent Pharma?

Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and known hypersensitivity to metformin. Caution is also advised for individuals with significant hepatic disease, heart failure, or a history of lactic acidosis.

Metformin, the active ingredient in Metformin Sr Crescent Pharma, is a Biguanide presented as an unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control.

GNH India supplies Metformin Sr Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Crescent Pharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin is indicated for conditions involving impaired glucose regulation and is used primarily in the management of type 2 diabetes.
Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
Prediabetes (impaired glucose tolerance): delays progression to overt diabetes.
Polycystic ovary syndrome (off‑label): helps restore ovulatory cycles and reduces insulin resistance.

How It Works

Metformin lowers hepatic glucose production by inhibiting mitochondrial respiratory‑chain complex I, which reduces gluconeogenesis. It also decreases intestinal glucose absorption and enhances peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK), facilitating glucose uptake in muscle and adipose tissue.

Side Effects

Metformin is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite.
Diarrhea: frequent loose stools, especially during treatment initiation.
Metallic taste: transient alteration in taste perception.
Flatulence: increased intestinal gas.
Weight loss: modest reduction in body weight.
Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects

Lactic acidosis: rare but potentially fatal metabolic acidosis.
Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
Hepatic dysfunction: elevated liver enzymes or hepatitis.
Hypoglycemia: when combined with insulin or sulfonylureas.
Acute pancreatitis: infrequent inflammatory pancreatic episodes.
Anemia: due to reduced red‑cell production in rare cases.

Precautions & Warnings

Metformin should be used with careful clinical monitoring and patient education.

Renal function assessment: evaluate creatinine clearance before initiation and periodically.
Hepatic function monitoring: avoid use in severe liver disease.
Contraindicated in severe renal impairment: do not use if eGFR <30 mL/min/1.73 m².
Risk of lactic acidosis: discontinue before radiologic contrast studies.
Use with caution in elderly patients: start at lower doses and monitor tolerance.
Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

Iodinated contrast agents: increase risk of lactic acidosis; withhold metformin before and after imaging.
Cimetidine: may raise metformin plasma concentrations.
Alcohol: potentiates lactic acidosis, especially in patients with hepatic disease.

Moderate Interactions (Monitor Closely)

Thiazide diuretics: can impair renal function, raising metformin levels.
Beta‑blockers: may mask hypoglycemia symptoms.
ACE inhibitors or ARBs: monitor renal function and electrolytes.
NSAIDs: may reduce renal clearance of metformin.
Certain antiretrovirals (e.g., protease inhibitors): may increase metformin exposure.

Frequently Asked Questions

Metformin Sr Crescent Pharma contains metformin hydrochloride, a Biguanide indicated for the management of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving the body’s response to insulin and reducing hepatic glucose output.

Metformin acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis. It also activates AMP‑activated protein kinase (AMPK), enhancing peripheral insulin sensitivity and decreasing intestinal glucose absorption, thereby lowering overall blood glucose.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Metformin may be prescribed during pregnancy for certain indications such as gestational diabetes, but the decision rests with the obstetrician. Limited data are available for breastfeeding; the prescriber should weigh potential benefits against any possible risks to the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin is often preferred as first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycemia when used alone. Compared with sulfonylureas or insulin, it has a different mechanism—targeting hepatic glucose production rather than stimulating insulin secretion.

Store the product at ambient temperature, below 25 °C, in the original packaging. Keep it away from moisture, direct sunlight, and heat sources to maintain stability and potency throughout its shelf life.

Metformin Sr Crescent Pharma is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water; they should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but life‑threatening condition that can occur in patients with severe renal or hepatic impairment, or after exposure to iodinated contrast. Prompt medical attention is required if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and known hypersensitivity to metformin. Caution is also advised for individuals with significant hepatic disease, heart failure, or a history of lactic acidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.